10 results
The aim of this research is to gain a more detailed insight into the illness perceptions of patients with lung cancer. With this insight it is our aim to improve biopsychosocial care for these patients. Research question: What are the illness…
Determine arm and shoulder function and quality of life scores before and after treatment of SST. The untreated extremity can serve as a control.Determine riskfactors for a poor functionale outcome and quality of life after treatment for SST (e.g.…
The main objective of the study is to monitor the factors effecting success of PDT, namely oxygen, photosensitizer concentration and, light dose before and during illumination to gather data that can be clinically correlated and later implemented.
Primary:To evaluate the effects of a rehabilitation program on health related quality of life (SGRQ) in the 12 months postoperative period in patients with an elective thoracotomy.Secondary:To evaluate the effects of a rehabilitation program on…
Investigate the phenotype, function and regulation of TRM in healthy human lung tissue, lung tumors and peripheral blood to improve the understanding of respiratory diseases and adoptive T-cell therapy for lung cancer.
The aim of the study is to evaluate the change of lung function at least one year after definitive chemoradiation (concurrent or sequential) in patients with locally advanced (non) small cell lung carcinoma to assess late radiation injury in our…
The aim of the study is to evaluate the change of lung function at least one year after definitive chemoradiation (concurrent or sequential) or radiotherapy alone in patients with locally advanced (non) small cell lung carcinoma to assess late…
The primary aim of the study is to compare the effect of PRO symptom monitoring with standard care on QoL both during and up to 1 year after treatment. Secondary aims are studying the effect of PRO symptom monitoring compared to standard care on the…
- Comparing the heterogeneity of the original tumour and its metastases.- Comparing the mutations in CTC*s to those of both the original tumour and the metastatic processes.- Assessing whether certain mutations precede the others (so called trunk…
Research question and objectives: To explore whether genetic/genomic markers (alone or combined with clinical covariates) could be used to predict OS in NSCLC patients treated with Vargatef® according to the approved label.